MDR-TB treatment in prison setting Source: Annual Congress 2007 - Tuberculosis control in the penitentiary and civilian sector Year: 2007
Psychiatric disorders in MDR TB patients on the treatment regimens under DOTS-plus programme in Tomsk oblast penitentiary system Source: Eur Respir J 2001; 18: Suppl. 33, 513s Year: 2001
Out-patient MDR-TB care in Moldova Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
Impact of social support programme on MDR-TB patients' treatment outcomes Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014
Outcomes of individualized treatment for MDR TB in Iran Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis Year: 2007
Improving treatment adherence in TB patients using rehabilitation activities for co-morbid addiction conditions within Tomsk penitentiary system Source: Annual Congress 2007 - Tuberculosis control in the penitentiary and civilian sector Year: 2007
Palliative care for MDR-TB patients in Latvia Source: Annual Congress 2013 –Palliative care in respiratory diseases: is it becoming overdue? Year: 2013
Sputum culture conversion among the first cohorts of MDR-TB patients managed in Nigeria at a tertiary care hospital Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014
The health economics of treating MDR-TB in the Indian private sector Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system Year: 2016
Centralization of M/XDR-TB care in clinical reference centres in Portugal. Experience of a regional reference centre Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Pattern of drug resistance in TB patients treated at DR TB unit in tertiary care public sector hospital in Karachi Pakistan Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
A comparison of drug sensitivity pattern in category-I failure versus category-I relapse pulmonary TB patients attending a tertiary care hospital in South Punjab, Pakistan. Is WHO category-II ATT regimen appropriate? Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
Improvement of TB epidemiological situation in Tomsk Oblast within the MDR-TB treatment program Source: Annual Congress 2008 - Asthma and miscellaneous disorders Year: 2008
Tuberculosis treatment defaulters in a Greek hospital Source: Eur Respir J 2003; 22: Suppl. 45, 40s Year: 2003
Treatment outcome of MDR pulmonary tuberculosis in a tertiary care hospital of Karachi, Pakistan Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Effectiveness of TB diagnostics with microbiological methods in TB service and general health care institutions Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis Year: 2011
Aspects of effective MDR-TB treatment in the prison hospital, Tomsk (Russia) Source: Eur Respir J 2006; 28: Suppl. 50, 17s Year: 2006
Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use Source: Eur Respir J, 50 (1) 1700311; 10.1183/13993003.00311-2017 Year: 2017
Time to sputum culture conversion as a prognostic marker for end-of-treatment outcome in the first cohorts of MDR-TB patients managed in a Nigerian tertiary hospital Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016
Effectiveness of national standardized and WHO regimens and risk factors of unfavorable outcomes in treatment of patients with MDR-TB in Novosibirsk Oblast, Russian Federation Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014